Sophie Samuel

8PUBLICATIONS
0CO-AUTHORS
Autonomic nervous systemRespiratory diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2026
Association Between Renin-Angiotensin System Inhibitors and Antiseizure Medication Burden in Critically Ill Patients With Status Epilepticus.

|Sep 04, 2024
A systematic review of the timing of therapeutic anticoagulation in adult patients with acute traumatic brain injury: narrative synthesis of observational studies.

Sophie Samuel, Jennifer Cortes, Eugene Uh

|Mar 19, 2024
Reviving Decades-Old Wisdom: Longitudinal Analysis of Renin-Angiotensin System Inhibitors and Its Effects on Acute Ischemic Stroke to Improve Outcomes.

Sophie Samuel, Kyndol Craver, Charles Miller

|Feb 28, 2024
Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review.

Ariel N Carrion, Teresa A Allison, Sophie Samuel

|Apr 07, 2023
Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.

Sophie Samuel, Wen Li, Koren Dunn

|Jan 09, 2023
Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.

Sophie Samuel, Catherine To, Yaobin Ling

Pageof 2

Frequent Collaborators